Sponsor:
Vaxcyte, Inc.
Code:
NCT06720038
Conditions
Pneumococcal Vaccines
Eligibility Criteria
Sex: All
Age: 42 - 70+
Healthy Volunteers: Accepted
Interventions
0.5 mL of the low dose VAX-31
0.5 mL of the mid dose VAX-31
0.5 mL of the high dose VAX-31
0.5 mL dose of PCV20
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by Vaxcyte, Inc. on 2025-05-04.